[Conbercept Reverses TGF-β-induced Epithelial-mesenchymal Transition in Human Lens Epithelial Cells by Regulating the TGF-β/Smad Signaling Pathway]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2024 Sep 14

PMID 39276041

Authors

M Zhu

J Wang

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the mechanism by which conbercept reverses transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition (EMT) in human lens epithelial cells (HLECs).

Methods: Cultured HLEC SRA01/04 cells were treated with TGF-β, conbercept, or both, and the changes in cell proliferation, apoptosis, and migration were observed using MTT assay, flow cytometry, scratch assay, and Transwell assay. Western blotting and qRT-PCR were used to detect the changes in the expression of EMT-related epithelial cell markers (E-Cadherin, α-SMA, and Snail), extracellular matrix components, and genes related to the TGF-β/Smad signaling pathway.

Results: Conbercept significantly reduced TGF-β-induced EMT of SRA01/04 cells, decreased the expression levels of mesenchymal and extracellular matrix markers α-SMA, Snail, collagen I, collagen IV, and FN1, and upregulated the protein and mRNA expressions of E-cadherin ( <0.05). Transwell assay showed significantly lower cell migration ability in TGF-β+conbercept group than in TGF-β group ( <0.05). Conbercept also inhibited the increase in Smad2/3 phosphorylation levels in HLEC-SRA01/04 cells with TGF-β-induced EMT ( <0.01).

Conclusion: Conbercept inhibits TGF-β induced EMT by downregulating the expression of pSmad2/3 in TGF-β/Smad signaling pathway, indicating a potential therapeutic strategy against visual loss induced by posterior capsule opacification.

References

Yoon D, Woo S . Intravitreal Administration of Ranibizumab and Bevacizumab for Choroidal Neovascularization Secondary to Ocular Toxocariasis: A Case Report. Ocul Immunol Inflamm. 2016; 26(4):639-641. DOI: 10.1080/09273948.2016.1239744. View

Lovicu F, Shin E, McAvoy J . Fibrosis in the lens. Sprouty regulation of TGFβ-signaling prevents lens EMT leading to cataract. Exp Eye Res. 2015; 142:92-101. PMC: 4654713. DOI: 10.1016/j.exer.2015.02.004. View

Bassey-Archibong B, Kwiecien J, Milosavljevic S, Hallett R, Rayner L, Erb M . Kaiso depletion attenuates transforming growth factor-β signaling and metastatic activity of triple-negative breast cancer cells. Oncogenesis. 2016; 5:e208. PMC: 4815049. DOI: 10.1038/oncsis.2016.17. View

Yum S, Jeong S, Kim D, Lee S, Kim W, Yoo J . Minoxidil Induction of VEGF Is Mediated by Inhibition of HIF-Prolyl Hydroxylase. Int J Mol Sci. 2018; 19(1). PMC: 5796003. DOI: 10.3390/ijms19010053. View

Li Y, Ren Q, Sun C, Li L, Lian H, Sun R . Efficacy and mechanism of anti-vascular endothelial growth factor drugs for diabetic macular edema patients. World J Diabetes. 2022; 13(7):532-542. PMC: 9329842. DOI: 10.4239/wjd.v13.i7.532. View

Masuyama N, Hanafusa H, Kusakabe M, Shibuya H, Nishida E . Identification of two Smad4 proteins in Xenopus. Their common and distinct properties. J Biol Chem. 1999; 274(17):12163-70. DOI: 10.1074/jbc.274.17.12163. View

Wanami L, Chen H, Peiro S, Garcia de Herreros A, Bachelder R . Vascular endothelial growth factor-A stimulates Snail expression in breast tumor cells: implications for tumor progression. Exp Cell Res. 2008; 314(13):2448-53. PMC: 2762866. DOI: 10.1016/j.yexcr.2008.05.004. View

Park B, Hwang E, Seo S, Cho J, Yang J, Yi T . Eucalyptus globulus extract protects against UVB-induced photoaging by enhancing collagen synthesis via regulation of TGF-β/Smad signals and attenuation of AP-1. Arch Biochem Biophys. 2017; 637:31-39. DOI: 10.1016/j.abb.2017.11.007. View

Fichtner J, Patnaik J, Christopher K, Petrash J . Cataract inhibitors: Present needs and future challenges. Chem Biol Interact. 2021; 349:109679. DOI: 10.1016/j.cbi.2021.109679. View

10.

Zhuravlyov A . [Posterior YAG capsulotomy: selection of the application pattern]. Ophthalmologe. 2021; 119(5):481-490. DOI: 10.1007/s00347-021-01526-x. View

11.

Hang A, Feldman S, Amin A, Ochoa J, Park S . Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Retinal Disorders. Pharmaceuticals (Basel). 2023; 16(8). PMC: 10458692. DOI: 10.3390/ph16081140. View

12.

Pozarowska D, Pozarowski P . The era of anti-vascular endothelial growth factor (VEGF) drugs in ophthalmology, VEGF and anti-VEGF therapy. Cent Eur J Immunol. 2016; 41(3):311-316. PMC: 5099389. DOI: 10.5114/ceji.2016.63132. View

13.

Trivedi R, Wilson M . Posterior capsule opacification in pediatric eyes with and without traumatic cataract. J Cataract Refract Surg. 2015; 41(7):1461-4. DOI: 10.1016/j.jcrs.2014.10.034. View

14.

Kikushima W, Sakurada Y, Sugiyama A, Tanabe N, Yoneyama S, Iijima H . Retreatment of polypoidal choroidal vasculopathy after photodynamic therapy combined with intravitreal ranibizumab. Jpn J Ophthalmol. 2016; 61(1):61-66. DOI: 10.1007/s10384-016-0479-4. View

15.

Saika S, Okada Y, Miyamoto T, Ohnishi Y, Ooshima A, McAvoy J . Smad translocation and growth suppression in lens epithelial cells by endogenous TGFbeta2 during wound repair. Exp Eye Res. 2001; 72(6):679-86. DOI: 10.1006/exer.2001.1002. View

16.

Fisus A, Findl O . Capsular fibrosis: a review of prevention methods and management. Eye (Lond). 2019; 34(2):256-262. PMC: 7002601. DOI: 10.1038/s41433-019-0723-5. View

17.

Lindholm J, Laine I, Tuuminen R . Five-Year Cumulative Incidence and Risk Factors of Nd:YAG Capsulotomy in 10 044 Hydrophobic Acrylic 1-Piece and 3-Piece Intraocular Lenses. Am J Ophthalmol. 2019; 200:218-223. DOI: 10.1016/j.ajo.2019.01.010. View

18.

Alon R, Assia E, Kleinmann G . Prevention of posterior capsule opacification by an intracapsular open capsule device. Invest Ophthalmol Vis Sci. 2014; 55(7):4005-13. DOI: 10.1167/iovs.14-14364. View

19.

Zhang R, Xie Z . Research Progress of Drug Prophylaxis for Lens Capsule Opacification after Cataract Surgery. J Ophthalmol. 2020; 2020:2181685. PMC: 7355348. DOI: 10.1155/2020/2181685. View

20.

Eldred J, Spalton D, Wormstone I . An in vitro evaluation of the Anew Zephyr open-bag IOL in the prevention of posterior capsule opacification using a human capsular bag model. Invest Ophthalmol Vis Sci. 2014; 55(11):7057-64. DOI: 10.1167/iovs.14-15302. View